Linden Thomson

Linden has over 12 years of experience in medical and biotechnology investing, including 5 years as an equity analyst at Goldman Sachs, before moving to the buy side where she worked as a pharmaceutical and technology analyst at the hedge fund Clear River Capital and finally to her current role at AXA. Linden is a CFA Charterholder and has a Bachelor’s degree in Medical Microbiology.

Manages these EQ rated funds
Fund EQ model portfolios holding this fund
AXA Framlington BiotechNot currently held in our model portfolios
See all our rated funds